14 research outputs found
Moxifloxacin susceptibility program (MSP): national and regional in vitro susceptibility of common respiratory tract pathogens
No full textDo Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?
No full textApplication of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients
No full textAntibiotic-Induced Release of Bacterial Cell Wall Components in the Pathogenesis of Sepsis and Septic Shock: a Review
No full text
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
No full textEffect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique
No full text
Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections
No full text
